Adicet’s Mission is to Deliver Best-in-Class Gamma Delta T Cell Therapies for Patients Fighting Autoimmune Diseases & Cancer
The power of gamma delta T cells
Gamma delta T cells represent a new generation of immune cell therapy
The Promise of Allogeneic Gamma Delta 1 CAR T Cell Therapy
Novel Targeting
Tissue Homing
Best-in-Class Drug Exposure
Available on Demand
Adicet’s novel platform enables us to potentially deliver therapies that are:
Recent News
November 29,
2024
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
November 18,
2024